Ayumed Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year,
- Last Filing with ROC 31 Mar 2024
About Ayumed Pharma
Ayumed Pharma Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 February 2006 and has a history of 19 years. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Yogiraj, Makkhan Yogi, and Vijay Yogiraj serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ2006PTC021999
-
Company No.
021999
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
What products or services does Ayumed Pharma Pvt Ltd offer?
Ayumed Pharma Pvt Ltd offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Ayurvedic Medicine, Ayurvedic Immunity Booster, Herbs,Sticks and Roots, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Ayurvedic Pain Relief Oil.
Who are the key members and board of directors at Ayumed Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Yogiraj
|
Director | 01-Feb-2006 | Current |
|
Makkhan Yogi
|
Director | 06-Jun-2017 | Current |
|
Vijay Yogiraj
|
Director | 06-Jun-2017 | Current |
Financial Performance of Ayumed Pharma.
Ayumed Pharma Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayumed Pharma?
In 2017, Ayumed Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rebanta Ayumed Limited Liability Partner ShipMakkhan Yogi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ayumed Pharma?
Unlock and access historical data on people associated with Ayumed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayumed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayumed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
